A novel enediyne‐integrated antibody–drug conjugate shows promising antitumor efficacy against CD30+ lymphomas.
- Resource Type
- Article
- Source
- Molecular Oncology; Mar2018, Vol. 12 Issue 3, p339-355, 17p
- Subject
- Language
- ISSN
- 15747891